Literature DB >> 2555392

Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection.

M P Landini1, T Lazzarotto, A Ripalti, M X Guan, M La Placa.   

Abstract

Significant epitopes of two of the major cytomegalovirus antigens, a nonstructural DNA-binding protein of 52 kilodaltons (kDa) and a structural phosphoprotein of 150 kDa, expressed as fusion proteins with the beta-galactosidase, were induced in Escherichia coli after infection with recombinant lambda gt11 clones. The epitopes were then used in immunoblotting to assay specific immunoglobulin G (IgG) and IgM in several groups of sera from long-term seropositive subjects and from patients undergoing primary or secondary virus infection. The data obtained showed that IgM reacting with the 52-kDa nonstructural antigen are linked to primary virus infection and can therefore be considered a serological marker of this infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555392      PMCID: PMC267017          DOI: 10.1128/jcm.27.10.2324-2327.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Precise localization of genes on large animal virus genomes: use of lambda gt11 and monoclonal antibodies to map the gene for a cytomegalovirus protein family.

Authors:  E S Mocarski; L Pereira; N Michael
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

2.  Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections.

Authors:  R F Pass; P D Griffiths; A M August
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

3.  A DNA-nicking activity associated with the nucleocapsid of human cytomegalovirus.

Authors:  M P Landini; A Ripalti
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Antibody response to cytomegalovirus polypeptides captured by monoclonal antibodies on the solid phase in enzyme immunoassays.

Authors:  N E Cremer; C K Cossen; G R Shell; L Pereira
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

5.  Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis.

Authors:  A Ripalti; M P Landini; E S Mocarski; M La Placa
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

6.  Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection.

Authors:  P D Griffiths; S Stagno; R F Pass; R J Smith; C A Alford
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

7.  Prospective study of cytomegalovirus infection in pregnancy.

Authors:  H Stern; S M Tucker
Journal:  Br Med J       Date:  1973-05-05

8.  Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus.

Authors:  L Rasmussen; D Kelsall; R Nelson; W Carney; M Hirsch; D Winston; J Preiksaitis; T C Merigan
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

9.  Protein counterparts of human and simian cytomegaloviruses.

Authors:  W Gibson
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

10.  Cytolytic IgM antibody to cytomegalovirus in primary cytomegalovirus infection in humans.

Authors:  R F Betts; S G Schmidt
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

View more
  13 in total

1.  Large-scale screening of human sera with cytomegalovirus recombinant antigens.

Authors:  M P Landini; M X Guan; G Jahn; W Lindenmaier; M Mach; A Ripalti; A Necker; T Lazzarotto; B Plachter
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides.

Authors:  M P Landini; A Ripalti; K Sra; P Pouletty
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

3.  Reactivity to p52 and CM2 recombinant proteins in primary human cytomegalovirus infection with a microparticle agglutination assay.

Authors:  E Nulens; M Bodéus; F Bonelli; A Soleti; P Goubau
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

4.  Humoral immune response to human cytomegalovirus DNA polymerase.

Authors:  M P Landini; T Lazzarotto; P F Ertl
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

Review 5.  Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.

Authors:  B Weber; W Braun; J Cinatl; H W Doerr
Journal:  Clin Investig       Date:  1993-04

Review 6.  Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.

Authors:  Maria Grazia Revello; Giuseppe Gerna
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

7.  Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay.

Authors:  M P Landini; T Lazzarotto; G T Maine; A Ripalti; R Flanders
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  Construction of polyepitope fusion antigens of human cytomegalovirus ppUL32: reactivity with human antibodies.

Authors:  A Ripalti; Q Ruan; M C Boccuni; F Campanini; G Bergamini; M P Landini
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

9.  Lack of correlation between virus detection and serologic tests for diagnosis of active cytomegalovirus infection in patients with AIDS.

Authors:  T Lazzarotto; P Dal Monte; M C Boccuni; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

10.  Prenatal diagnosis of congenital cytomegalovirus infection.

Authors:  T Lazzarotto; B Guerra; P Spezzacatena; S Varani; L Gabrielli; P Pradelli; F Rumpianesi; C Banzi; L Bovicelli; M P Landini
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.